Marissa D'Inca

Marissa D'Inca has extensive work experience in financial planning and analysis, with a focus on the pharmaceutical industry. Marissa has held various roles at different companies, showcasing their progression and expertise in the field.

Marissa's most recent position is Vice President, Head of Financial Planning & Analysis at Allogene Therapeutics, where they have been working since 2022. Prior to this, they served as the Executive Director and Senior Director, also in the same department, demonstrating their growth and leadership abilities.

Before joining Allogene Therapeutics, Marissa worked at Kite Pharma from 2015 to 2018. Marissa held the role of Sr. Director and Director of Financial Planning & Analysis during their time there.

Marissa began their career at Amgen in 2003. Marissa held several roles in finance, including Senior Manager in Contracts & Pricing, R&D Finance, and Corporate Business Analysis. Marissa'stime at Amgen spanned from 2003 to 2015.

Prior to their work at Amgen, Marissa gained consulting experience at Triage Consulting Group as a Consultant from 1997 to 2001.

Overall, Marissa D'Inca has a strong background in financial planning and analysis, with significant experience in the pharmaceutical industry.

Marissa D'Inca completed their Bachelor of Science degree in Biology at UCLA in 1997. In 1994 and 1995, they took part in a Study Year Abroad program at Queen Mary University of London as an undergraduate student. From 2001 to 2003, they pursued their Master of Business Administration (MBA) at the UCLA Anderson School of Management. During their MBA program, they also participated in a Study Abroad Semester at the Rotterdam School of Management, Erasmus University, in 2002.